IR
Ingersoll RandDAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
As of 2026-04-29, this appears closer to a T+1 follow-up than a true T+3 read. News flow is active but mixed: the earnings release confirmed a modest headline beat and unchanged guidance, while trusted post-print coverage described a roughly 4%-5% negative market reaction tied to organic weakness and margin compression. Confirmed analyst target/rating revisions are still limited in the checked evidence, so missing revision follow-through should be treated as an evidence gap rather than positive confirmation.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Q1 2026 reported orders of $1.978B (+5%), revenue of $1.847B (+8%), adjusted EPS of $0.77 and adjusted EBITDA of $469M, while management maintained FY2026 guidance for 2.5%-4.5% revenue growth, $2.13B-$2.19B adjusted EBITDA and $3.45-$3.57 adjusted EPS [#8-K-2026-04-28]. Trusted post-print coverage said EPS and revenue were modestly above consensus, but the stock still traded lower as investors focused on mix and organic softness.
Management said IT&S orders excluding the Middle East were approximately flat organically and that delayed Middle East orders are expected to be recovered through the balance of 2026; confirmation that this recovery is materializing would help de-risk the organic order narrative [#8-K-2026-04-28].
Management highlighted a robust M&A pipeline, deployed $52M in Q1 for Scinomix, and said the signed Fox s.r.l. acquisition was expected to close on April 30, 2026; with guidance assuming about 2% M&A contribution, clean integration and deal cadence remain important to hitting the annual revenue target [#8-K-2026-04-28].
Recommendation
No formal recommendation provided.

